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ABSTRACT The strong restriction barrier present in Staphylococcus aureus and Staphylococcus epidermidis has limited func-
tionalgenomicanalysistoasmallsubsetofstrainsthatareamenabletogeneticmanipulation.Recently,aconservedtypeIVre-
strictionsystemtermedSauUSI(whichspeciﬁcallyrecognizescytosinemethylatedDNA)wasidentiﬁedasthemajorbarrierto
transformationwithforeignDNA.Herewehaveindependentlycorroboratedtheseﬁndingsinawidelyusedlaboratorystrainof
S. aureus. Additionally, we have constructed a DNA cytosine methyltransferase mutant in the high-efﬁciency Escherichia coli
cloning strain DH10B (called DC10B). Plasmids isolated from DC10B can be directly transformed into clinical isolates of S. au-
reus and S. epidermidis. We also show that the loss of restriction (both type I and IV) in an S. aureus USA300 strain does not
haveanimpactonvirulence.CircumventingtheSauUSIrestrictionbarrier,combinedwithanimproveddeletionandtransfor-
mationprotocol,hasallowedthegeneticmanipulationofpreviouslyuntransformablestrainsoftheseimportantopportunistic
pathogens.
IMPORTANCE Staphylococcal infections place a huge burden on the health care sector due both to their severity and also to the
economicimpactoftreatingtheinfectionsbecauseofprolongedhospitalization.Toimprovetheunderstandingof Staphylococ-
cus aureus and Staphylococcus epidermidis infections, we have developed a series of improved techniques that allow the genetic
manipulationofstrainsthatwerepreviouslyrefractorytotransformation.Thesedevelopmentswillspeeduptheprocessofmu-
tantconstructionandincreaseourunderstandingofthesespeciesasawhole,ratherthanjustasmallsubsetofstrainsthatcould
previouslybemanipulated.
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F
unctional genomic analyses of the Gram-positive opportunis-
ticpathogensStaphylococcusaureusandStaphylococcusepider-
midis have been limited by the inability to manipulate genetically
the majority of clinical isolates. In general, wild-type strains of
S. aureus and S. epidermidis have an impenetrable restriction bar-
rier preventing the uptake of “foreign” DNA (1–3). A plethora of
knowledge has been generated through the mutagenesis of “labo-
ratory” S. aureus isolates such as Newman (4), 8325-4 (5), and
more recently some strains of the community-acquired
methicillin-resistant S. aureus (CA-MRSA) USA300 (6). For
S. epidermidis, the transformable strains 1457 (7) and O-47 (8)
have been the mainstay of genetic studies, but the genome se-
quences for these isolates are not currently available. The emer-
gence of CA-MRSA and the high frequency of methicillin resis-
tance found in hospital isolates of S. epidermidis have highlighted
the need to understand better the evolution and biology of these
medically important staphylococci at a genetic level (9, 10). The
majority of MRSA isolates currently cluster into ﬁve clonal com-
plexes(clonalcomplex5[CC5],CC8,CC22,CC30,andCC45)of
which only CC5 and CC8 have been successfully manipulated ge-
netically (9). Pathogenomic studies on CC5 and CC8 strains stem
fromtheisolationofS.aureusRN4220almost30yearsago.Thisis
a restriction-defective mutant that can still modify DNA, which
was obtained by extensive chemical mutagenesis of strain 8325-4
(11). Strain RN4220 accepts DNA derived from wild-type Esche-
richia coli, unlike the parental strain 8325-4. Passage of DNA
through RN4220 has allowed the subsequent transfer of DNA by
electroporation or generalized phage transduction to a small sub-
set of closely related strains, but not to more distantly related
S. aureus or S. epidermidis isolates.
Experimental evidence presented by Waldron and Lindsay (3)
suggestedthattheconservedtypeIrestriction-modiﬁcation(RM)
system was solely responsible for the inability to transform S. au-
reus isolates with E. coli-derived plasmid DNA. They identiﬁed a
premature stop codon in the type I restriction gene (hsdR)i nS.
aureus RN4220. Complementation with full-length hsdR ex-
pressed from a low-copy-number plasmid rendered strain
RN4220 incapable of accepting plasmids electroporated from
E. coli, reduced the rate of conjugation with Enterococcus faecalis,
and prevented transduction with phage isolated from a distantly
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wild-type S. aureus isolates did not yield a transformable strain,
suggesting at least one other pathway is involved. The gene re-
sponsible for preventing the transformation of S. aureus with
E. coli-derived plasmid DNA was recently identiﬁed and charac-
terized by Corvaglia et al. (1) in two clinical isolates of S. aureus
(UAMS-1 and SA564). The biochemical properties of the con-
served type IV modiﬁcation-dependent restriction endonuclease
(termed SauUSI) were subsequently characterized in detail (12).
Cytosine methylated DNA was identiﬁed as the motif recognized
by SauUSI, with plasmid isolated from a B strain of E. coli (which
is naturally a dcm mutant) able to bypass the type IV barrier.
Inactivation of both hsdR and sauUSI yielded a strain that was
transformable at equivalent efﬁciency with plasmid DNA isolated
eitherfromE.coliorfromtheparentalS.aureusstrain.Thesedata
demonstrate that only these two pathways contribute to the re-
striction barrier in the strains analyzed (12).
Here we have characterized the RM systems of the widely used
laboratory S. aureus strain Newman and corroborated the previ-
ous ﬁndings (1, 12). We have created a dcm mutation in the high-
efﬁciency E. coli cloning strain DH10B (called DC10B). We show
that direct transformation can be performed with plasmid DNA
isolated from DC10B, but not the progenitor DH10B, into S. au-
reusstrainsfromthemajorityofclonalcomplexestested.Further-
more,weshowthatS.epidermidiscontainsanorthologofSauUSI
(termedMcrR)whichalsorecognizescytosinemethylation.McrR
canalsobebypassedwithplasmidDNAisolatedfromDC10B.To
take advantage of these ﬁndings, we have developed a robust
methodforcreatingmutationsbyallelicexchangeinbothlabora-
tory strains and previously untransformable strains of S. aureus
and S. epidermidis and have developed an improved electropora-
tion protocol. The virulence in an intravenous mouse infection
model of S. aureus USA300 strain NRS384 was not affected by the
mutation of hsdR or sauUSI singly or in combination. These de-
velopments open up previously recalcitrant strains of S. aureus
and S. epidermidis to genetic analysis, which will ultimately im-
prove our understanding of these important pathogens.
RESULTS AND DISCUSSION
Bypassing the restriction barrier. Transformation of S. aureus
strain Newman by the protocol of Augustin and Götz (13) with
5gofshuttleplasmidpRMC2DNA(14)isolatedfromthewild-
type E. coli K-12 strain BW25113 (15) consistently failed to yield
transformants. Similar results were observed with plasmid iso-
lated from the high-efﬁciency cloning strain of E. coli K-12,
DH10B.However,iftheplasmidwasisolatedfromtherestriction-
defective S. aureus strain RN4220 or from strain Newman itself,
we would routinely obtain 104 CFU with the same concentration
of pRMC2. These results show that a strong restriction barrier is
presentintheNewmanstrain,whichimpedestheuptakeofE.coli
K-12-derivedplasmidDNA.Whenweappliedtheelectroporation
protocol for Staphylococcus carnosus developed by Löfblom et al.
(16), we observed a 50-fold improvement in the transformation
efﬁciency, and for the ﬁrst time, a low number of transformants
were obtained with plasmid DNA isolated from strain BW25113
(Fig. 1). A second advantage of the S. carnosus protocol is the
reduced time required for production of competent cells (2 h in-
stead of 4 h). The protocol is also applicable to S. epidermidis,
albeit with a marked reduction in efﬁciency (a maximum of
103CFUwasobtainedinS.epidermidisRP62awithpRMC2DNA
isolated from the same strain).
ConstructionofpIMAY.TheroleofRMwasassessedbyCor-
vaglia et al. (1) in two clinical strains using the targetron system
(17) for gene disruption rather than the more traditional allelic
exchange approach for the creation of marked or unmarked mu-
tations. The targetron system is useful for the rapid disruption of
genes and for testing gene essentiality. However, allelic exchange
allows precise control over the mutation allowing the deletion of
entire genes, introduction of point mutations, insertion of hybrid
genes, and gene restoration to eliminate the possibility of polar
effects (18). The plasmid pE194ts replicon is commonly used for
allelic exchange in staphylococci, as exempliﬁed by pKOR1 (19).
Chromosomal integration of the plasmid requires growth at the
high temperature of 43°C (19). It was reported recently that mu-
tations in the sae genes encoding a two-component system can be
selected during growth at high temperature in the presence of the
antibiotic erythromycin or chloramphenicol (20). To avoid these
concerns, we have developed a new vector for allelic exchange in
staphylococci called pIMAY (Fig. 2 and 3A). The vector utilizes
the plasmid pWV01ts replicon (21), which is highly temperature
sensitiveinstaphylococciandthusallowsplasmidintegrantstobe
selectedat37°C.PCRcaneasilybeappliedto(i)demonstratethat
extrachromosomal plasmid is no longer present with primers ex-
ternal to the multiple cloning site (MCS) on pIMAY (IM151 and
IM152 [IM151/IM152] [Fig. 3B]) and (ii) determine whether
plasmidintegrationhasoccurredviatheupstreamordownstream
region of homology cloned into pIMAY (Fig. 3C). Growth at a
temperature permissive for pIMAY replication (below 30°C) and
the induction of secY antisense RNA (derived from pKOR1) pre-
ventsgrowthofcellsthatretaintheintegratedplasmidandselects
for cells that have lost the plasmid (19). Additionally, a high level
of chloramphenicol (Cm) resistance is obtained by expression of
cat from a strong promoter (22). This reduces the pressure for
selection of variants with increased Cm resistance, which, com-
binedwiththelowcopynumberoftheplasmid,lessensthechance
of tandem duplication occurring during chromosomal integra-
tion.
DeletionofhsdRandsauUSIinS.aureusNewman.Toassess
the roles of hsdR (encodes the restriction component of a type I
RM system) and sauUSI (encodes a type IV restriction gene) in S.
FIG 1 Transformation of S. aureus Newman and isogenic mutants defective
inrestriction.ConcentratedpRMC2DNA(5g)isolatedfromS.aureusNew-
man, E. coli BW25113 (dam dcm), or E. coli IBEC55 (dam) were electro-
porated into Newman or Newman restriction mutants. The transformation
efﬁciency was expressed as the mean number of all transformants obtained in
each experiment  standard deviation (error bar) of three replicates. The
graph shows data representative of the data from three independent experi-
ments.
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of the genes and a double mutant with pIMAY. No differences in
delta toxin production, hemolysis, growth rate, or ﬁnal growth
yield were observed for the mutants compared to Newman (data
notshown)indicatingtheintegrityofAgrandSae.Wethentrans-
formed wild-type Newman and Newman hsdR, Newman
sauUSI, and Newman hsdR sauUSI mutants with pRMC2
DNAisolatedfromeitherNewman,E.coliBW25113(damdcm
hsd)o rE. coli IBEC55 (dam only) (15). In line with the exper-
imental evidence presented for the clinical isolate UAMS-1 (1),
the Newman hsdR sauUSI mutant exhibited the highest trans-
formation efﬁciency, which was equivalent to wild-type Newman
transformed with plasmid DNA isolated directly from Newman
(Fig.1).Incontrast,aca.130-foldreductioninthetransformation
efﬁciencyofstrainNewmanwasobservedwithplasmidDNAiso-
lated from E. coli IBEC55. Transformation of the hsdR mutant
with plasmid DNA isolated from strain IBEC55 yielded a high
transformationefﬁciencyequivalenttothatofDNAisolatedfrom
Newman or transformation into Newman hsdR mcrR mutant.
Our data have also shown that the role of the type I RM system in
Newman is to prevent the uptake of DNA from other staphylo-
cocci as well as from foreign sources. Plasmid DNA isolated from
either Dcm or Dcm E. coli was transformed into the sauUSI
mutant at a ca. 100-fold reduced level compared to plasmid DNA
isolated from wild-type Newman (Fig. 1). The gene upstream of
sauUSI is predicted to encode a nudix hydrolase which is poten-
tially involved in the degradation of mutagenic nucleotide
triphosphates (23). Deletion of this gene did not yield the same
transformable phenotype observed in the sauUSI strain (data
not shown), which suggests that the putative nudix hydrolase is
not required for SauUSI activity.
In S. aureus RN4220, premature stop codons are present in
hsdR and sauUSI, producing a strain that can modify, but not
restrict, foreign DNA. We restored the sauUSI mutation to the
wild type, creating the RN4220 sauUSI strain, which was poorly
transformable with E. coli-derived pRMC2 DNA with 102 trans-
formants compared to 106 CFU for RN4220. This conﬁrms a
dominant role for sauUSI over hsdR as was also observed in New-
man.
C-terminally His-tagged SauUSI is an endonuclease. To
characterize the barrier to transformation encoded by sauUSI,w e
assessed the function of the puriﬁed SauUSI protein. The full-
length SauUSI protein of Newman was expressed in E. coli
BL21(DE3)frompET21d(C-terminalhexahistidinetagvector)
and puriﬁed by nickel afﬁnity chromatography, yielding SauUSI-
his. We then tested the effect of incubating SauUSI-his with
pRMC2 DNA isolated from a panel of isogenic methylation-
defective mutants of E. coli BW2511. The pRMC2 DNA proﬁles
(Fig. 4A) demonstrate that SauUSI-his can digest plasmid DNA
isolated from both E. coli BW25113 (dam dcm hsd) and
IBEC56 (dcm only), while pRMC2 isolated from E. coli IBEC55
(dam only), IBEC57 (hsd only), and IBEC58 (unmethylated)
was unaffected. This indicates that cytosine methylation is the
signal that is recognized by SauUSI. This occurs in all strains de-
rivedfromE.coliK-12(e.g.,DH5,TOP10,orXL1-Blue)butnot
in those derived from E. coli B (e.g., BL21). For this reason, we
could express SauUSI-his in strain BL21 without toxicity. There
was also a strict requirement for ATP, as DNA digestion was not
observedwhenATPwasomittedfromthebuffer.Thefrequencies
of transformation of S. aureus Newman and Newman sauUSI
with pRMC2 isolated from E. coli BW25113 and the methylation
mutants were consistent with the digestion proﬁles, with wild-
typeNewmanbeingtransformedefﬁcientlyonlyifcytosinemeth-
ylation was absent from the DNA (Fig. 4B).
Isolating mutations in S. epidermidis RP62a and S. aureus
Cowan. We sought to apply these ﬁndings and to attempt allelic
exchange in the genome-sequenced S. epidermidis strain RP62a
(24) and S. aureus Cowan (25), two strains that we had not previ-
ously been able to manipulate genetically. We were able to trans-
form both strains with pIMAY isolated from E. coli IBEC55 (at a
very low efﬁciency for RP62a) and subsequently to construct mu-
tations in the sauUSI-like genes in each. We called the gene of
S. epidermidis RP62a mcrR for methylated cytosine recognition
and restriction. Similar transformation proﬁles were obtained as
observedforS.aureusNewmanwithregardtotheinvolvementof
cytosine methylation (Fig. 5). Additionally, the CA-MRSA strain
NRS384 and the isogenic sauUSI targetron mutant also had the
same transformation proﬁle as Newman and Newman sauUSI
mutant (Fig. 5). However, Cowan exhibited a strict requirement
forthepresenceofadeninemethylationonthetransformingplas-
midDNA,astransformantscouldnotbeobtainedinitsabsencein
either the wild type or sauUSI mutant. Out of 15 S. aureus strains
used in this study, only Cowan genomic DNA was sensitive to
digestion with the restriction enzyme DpnI, which recognizes ad-
enine methylation at a 5= GATC 3= motif. This suggests the
FIG 2 Genetic map of pIMAY. The E. coli/staphylococcal temperature-
sensitive plasmid pIMAY comprises the low-copy-number E. coli origin of
replication(p15A),anoriginoftransferforconjugation(oriT),thepBluescript
multiple cloning site (MCS), and the highly expressed cat gene (Phelp-cat)
derived from pIMC (34). The temperature-sensitive replicon for Gram-
positive bacteria (repBCAD) and the tetracycline-inducible antisense secY re-
gion (anti-secY) were ampliﬁed from pVE6007 (21) and pKOR1 (19), respec-
tively. The restriction sites listed are unique. Primers (IM151/152) bind
externaltotheMCSofpIMAYandareusedtoscreenclonesinE.coli(amplify
283 bp without a cloned insert) and to determine the presence of a replicating
plasmid in staphylococci.
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indicates the possibility of an additional restriction system in this
strain.
CreationofE.coliDC10B—auniversalstaphylococcalclon-
ing host. E. coli IBEC55 is not an ideal cloning host, as it does not
containmutationsassociatedwiththeproductionofgood-quality
plasmid DNA (recA endA) and is not highly transformable.
Throughrecombineering(recombination-mediatedgeneticengi-
neering) (26) in a high-efﬁciency cloning strain of E. coli
(DH10B),wecreatedDC10B,amutantwiththedcmgenedeleted.
Plasmid DNA isolated from DC10B was capable of transforming
Newman at the same efﬁciency as that of IBEC55 (data not
shown). Eleven representative S. aureus strains from a diverse se-
lectionofmultilocussequencetypes(STs)(Fig.6A)andS.epider-
midis RP62a were tested as recipients for transformation with
pRMC2 DNA isolated from either
DH10BorDC10B(Fig.6B).Strainsfrom
sequence type 1 (ST1), ST8, ST10, ST22,
ST30, ST36, and ST45 could be trans-
formed only with DNA from E. coli
DC10B, while ST5, ST25, and ST121
yielded colonies irrespective of the plas-
midsource.ThiswasexpectedfortheST5
strain N315, because a premature stop
codon is present in the sauUSI gene. We
have not investigated the restriction sta-
tus of the transformable ST25 and ST121
clones. The isolate chosen from ST97 did
not transform with plasmid DNA from
either DH10B or DC10B. It is possible
that this strain requires different growth
conditionsortreatmentspriortoelectro-
poration to become competent (1) or an
additional RM system may be present
(27). When pRMC2 was reisolated from
the different hosts, no evidence of dele-
tion or rearrangement was observed (see
Fig. S1 in the supplemental material).
E. coli dam mutants have a higher fre-
quency of spontaneous mutation com-
pared to wild type or dcm mutants (41).
Thus, the dcm mutant of DH10B is an
ideal host for the construction of recom-
binant plasmids for subsequent direct
transformationintoS.aureusorS.epider-
midis. We are currently investigating the
possibility of bypassing the type I restric-
tion barriers in S. aureus by E. coli to fur-
ther improve the transformation efﬁ-
ciency. The knowledge gained here could
be applied to other bacteria where DNA
uptake is impeded by RM.
Impact on virulence of restriction
mutants of S. aureus USA300 strain
NRS384.Wesoughttoassesstherolethat
RMsystemsmightplayininﬂuencingthe
ability of bacteria to grow in vivo. Instead
of using the laboratory strain Newman,
we constructed restriction-deﬁcient mu-
tations in the CA-MRSA strain NRS384
(NARSA USA300-014 clone) using the targetron system. The
double mutant (hsdRINT sauUSIINT) was reverted by allelic ex-
change to restore wild-type sauUSI (Fig. 7A). The strains were
phenotypically identical with no morphological or growth rate
differences. The transformation proﬁles were similar to those ob-
served for Newman. Restoration of sauUSI in the double mutant
dramatically reduced the transformation frequency (Fig. 7B). In
the AJ mouse intravenous infection model, no signiﬁcant differ-
ences in the bacterial numbers recovered from the kidneys at day
7 were observed (Fig. 7C). Under the conditions tested, the con-
served type I RM and type IV restriction system do not affect the
virulence of S. aureus.
Cytosine methylation—a barrier for DNA transfer? Previ-
ously, it was shown that plasmid DNA isolated from Enterococcus
faecalis (a major potential reservoir of vancomycin resistance)
FIG 3 Schematic of allelic exchange with pIMAY. (A) A plasmid isolated from E. coli DC10B is
transformed into staphylococci at 28°C, and single-crossover (SCO) integration was stimulated by
growthat37°Cinthepresenceofchloramphenicol.Thelossofreplicatingplasmidisassayedbycolony
PCR with MCS primers (IM151/IM152). Clones negative for replicating plasmid are then screened for
the side of integration with a combination of chromosomal and cloning primers (e.g., OUT FWD/D
REV[ABintegration{ABINT}]orOUTREV/AFWD[CDintegration{CDINT}]).Thediagramdetails
an integration event through the AB side (equivalent to clone h in panels B and C). A clone from either
AB or CD integration event is grown at 28°C in broth without antibiotic selection to stimulate rolling
circle replication and then plated on TSA with 1 g/ml ATc. Expression of the secY antisense RNA
(a-secY) inhibits growth of cells maintaining the plasmid. Plasmid excision through the AB side re-
createsthewild-typelocus,whileCDexcisionyieldsamutatedgene.(B)ColonyPCRfrom10randomly
chosenclones(clonesatoj)aftergrowthat37°Cforthepresenceofreplicatingplasmid.Theabsenceof
product indicates that the plasmid has integrated. Colony PCR from cells grown at 28°C is included as
a positive control (ve). (C) Two clones without replicating plasmid (clones c and h) were shown by
colonyPCRtohaveintegratedeitherontheAB(upstream[cloneh])orCD(downstream[clonec])side
of the gene to be deleted. Wild-type (WT) genomic DNA was included as a control.
Monk et al.
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letion in sauUSI was ﬁrst constructed (1). This suggests that a
barriertoplasmidtransferbetweenE.faecalisandS.aureusmight
becytosinemethylation.FromthegenomesequencesofE.faecalis
strainssubmittedtopublicdatabases,wecouldidentifyaputative
cytosine methyltransferase in all strains examined. However,
when genomic DNA was isolated from E. faecalis strains OG1RF,
V583, and JH2-2 (grown in brain heart infusion broth [BHI] at
37°C), only DNA from OG1RF could be digested with puriﬁed
SauUSI (data not shown), suggesting that some E. faecalis strains
butnototherscouldpotentiallyactasreservoirsforthetransferto
DNA to S. aureus. Naturally occurring vancomycin-resistant
S. aureus clones are all in ST5 (CC5) (28). Both genome-
sequenced isolates from CC5 (29) contain a truncated version of
thesauUSIgene,leadingtothepossibilitythatacquisitionofvanA
mediated by conjugation from enterococci could occur in strains
thatlackfunctionalsauUSI.FurtherinvestigationintothesauUSI
status of vancomycin-resistant strains of S. aureus is required.
Summary. The availability of the E. coli dcm mutant (DC10B)
along with an improved transformation protocol and the con-
struction of the temperature-sensitive
plasmidpIMAYhasdramaticallyacceler-
ated our ability to generate mutations in
staphylococci.Wehavebeensuccessfulin
creating mutations in S. aureus strains
Newman, NRS384 (USA300), and
Cowan and S. epidermidis RP62a as de-
scribed above but also in the hospital-
acquired MRSA (HA-MRSA) strain
MRSA252 (CC30) and two additional
CA-MRSA strains (TCH1516 and LAC,
both CC8). From the start of cloning to
the conﬁrmation of the mutation takes
2 weeks, under conditions that are less
stressful to the bacterium to be altered
than previously published protocols.
Breaking the restriction barrier opens up
clinical isolates such as MRSA lineages
CC22, CC30, and CC45 to genetic ma-
nipulation (e.g., allelic exchange and
transposon mutagenesis) and will ulti-
mately improve our understanding of
staphylococcal genetics, potentially lead-
ing to novel methods to combat these
deadly opportunistic pathogens.
MATERIALS AND METHODS
Media and reagents. Bacterial strains, plas-
mids, and oligonucleotides used in this study
are described in Table 1. E. coli, S. aureus, and
S. epidermidis were routinely cultured at 37°C
in L broth (1% tryptone, 0.5% yeast extract,
0.5% NaCl), Trypticase soy broth (TSB)
(Difco) or brain heart infusion broth (BHI)
(Difco). For growth on agar, L broth or brain
heart infusion broth was solidiﬁed with 1.5%
agar, yielding LBA and BHIA, respectively.
The following antibiotics and concentrations
were used: chloramphenicol (Cm), 10 g/ml;
kanamycin, 50 g/ml; erythromycin (Em),
25 g/ml; and carbenicillin, 100 g/ml
(Sigma).
Oligonucleotides and DNA sequencing were purchased from IDT.
Restriction enzymes and LigaFAST T4 DNA ligase were purchased from
NEB and Promega, respectively. High-ﬁdelity PCR was performed with
KODHotstartDNApolymerase(Novagen)orPhusionDNApolymerase
(Finnzymes) on genomic DNA isolated with the Genelute bacterial
genomic DNA kit (Sigma). Plasmids and PCR products were puriﬁed
usingWizardPluskits(Promega).ToisolateplasmidDNAfromS.aureus,
a 10-ml overnight culture was treated with 100 g lysostaphin (Ambi
Products, New York) in P1 buffer for 30 min at room temperature and
then processed as recommended by the manufacturer (GeneJET plamsid
miniprep kit; Fermentas).
ForcolonyPCR,asmallamountofcolonialgrowthwastouchedtothe
side of a PCR tube and microwaved for 5 min at 800 W. The tube was
placed on ice, Phire Hotstart II master mix (Finnzymes) was added to the
PCR tube, and thermocycling conditions were conducted as recom-
mended by the manufacturer.
Construction of temperature-sensitive plasmids pIMC5 and
pIMAY. A new temperature-sensitive vector was constructed for allelic
replacementmutagenesisinS.aureus.Thevectorisbasedonthereplicon
ofthelactococcalplasmidpWV01ts(frompVE6007[21])ratherthanthe
commonly used staphylococcal pE194ts replicon (30). A hybrid vector
FIG 4 Assays for the activity of SauUSI. (A) The shuttle plasmid pRMC2 was isolated from isogenic
E. coli methylation mutants and incubated in NEB ligation buffer with () or without () puriﬁed
SauUSI-his for1ha t37°C. The DNA was then puriﬁed and run on a 1% agarose gel. The positions of
linearized (6.4 kb) (L), relaxed circular (RC), covalently closed circular (CCC), and multimers (M) of
pRMC2 are indicated by the black arrowheads to the right of the gel. (B) Concentrated pRMC2 DNA
(5 g) isolated from isogenic E. coli methylation mutants was electroporated into either S. aureus
Newman or Newman sauUSI mutant. The transformation efﬁciency was expressed as the total num-
ber of transformants obtained in each experiment  standard deviation (error bar) of three replicates.
The graph shows data representative of the data from three independent experiments.
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prises (i) the repBCAD(Ts) genes from pVE6007 and (ii) the E. coli back-
bone p15A rep and pBluescript KS multiple cloning site and the highly
expressed chloramphenicol acyltransferase marker from pIMC (31). The
counterselection marker encoding tetracycline-inducible antisense secY
RNA was ampliﬁed from pKOR1 and intro-
duced between the novel BglII and SphI sites
to form pIMAY.
Electroporation. Electroporation was
conductedessentiallyasdescribedbyLöfblom
et al. (16). Overnight cultures of S. aureus or
S. epidermidis were grown in 10 ml of either
TSB or BHI (in 50-ml tubes) and then diluted
to an optical density at 578 nm (OD578)o f0 . 5
in fresh prewarmed media. The cultures were
reincubated for 30 min and then chilled in an
ice slurry for 10 min, with all subsequent steps
performed at 4°C on ice. The cells were har-
vested at 4,000  g for 10 min, and the pellets
were resuspended in an equal volume of auto-
claved ice-cold water. The centrifugation and
resuspension steps were repeated. The cells
were then repeatedly centrifuged and resus-
pendedﬁrstin1/10,thenin1/25,andﬁnallyin
1/200 the volume of autoclaved ice-cold 10%
(wt/vol)glycerol.Aliquotsof50lwerefrozen
at 70°C. For electroporation, cells were
thawed on ice for 5 min and then left at room
temperature for 5 min before being centri-
fuged (5,000  g for 1 min) and resuspended
in 50 l of 10% glycerol and 500 mM sucrose
(ﬁlter sterilized). Plasmid DNA (5 g) was
precipitated with pellet paint (Novagen) and
added to the cells, transferred to a 1-mm elec-
troporation cuvette (Bio-Rad) at room tem-
perature, and pulsed at 21 kV/cm, 100 , and
25F.Thecellswereincubatedin1mlofTSB
supplemented with 500 mM sucrose (ﬁlter
sterilized), incubated at 28°C or 37°C for 1 h
before plating on BHIA plus 10 go fC mp e r
ml (Cm10), and incubated at 28°C or 37°C.
Allelic exchange with pIMAY. Deletion
constructsforthehsdR,sauUSI,sauUSIECORV,
and mcrR genes and a putative nudix
hydrolase-encoding gene (Table 1) were PCR
ampliﬁed as follows. A sequence upstream of the gene to be deleted was
ampliﬁedwitholigonucleotidesAandB(A/B)(uptothestartcodon)and
thedownstreamsequencewitholigonucleotidesC/D(downfromthestop
codon) separately. The upstream and downstream PCR products were
FIG5 TransformationofS.aureusCowan,S.epidermidisRP62a,andS.aureusNRS384.pRMC2DNA
(5g)isolatedfromisogenicE.colimethylationmutantswaselectroporatedintoeitherthewildtypeor
the corresponding sauUSI or mcrR mutant of the strain speciﬁed. The transformation efﬁciency is
expressedasthetotalnumberoftransformantsobtainedineachexperimentwithstandarddeviationof
three replicates. An asterisk denotes that no transformants were detected.
FIG6 Transformation of strains from a diverse selection of S. aureus sequence types and an S. epidermidis isolate. (A) Phylogenetic relatedness of the S. aureus
strains selected for transformation, adapted from reference 35 with permission of the publisher. Representative sequence types used for transformation are
highlighted in bold type. (B) Concentrated pRMC2 DNA (5 g) isolated from E. coli DH10B (dam dcm) or DC10B (dam) was electroporated into strains
from different S. aureus STs (denoted by the number on the x axis) including strains Cowan, MRSA252, N315, LAC, and S. epidermidis RP62a. The transfor-
mation efﬁciency was expressed as the total number of transformants obtained in each experiment  standard deviation of three replicates. An asterisk denotes
that no transformants were detected. The graph shows data from one experiment.
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PCR with the A/D primers. Deletion constructs were cleaved at endonu-
clease sites introduced into A and D primers during PCR and ligated into
pIMAY cut with the same enzymes and then transformed into E. coli
DC10B.TheplasmidDNAwassequenced.TheDNAwasthenelectropo-
rated into the target strain and plated onto BHIA plus Cm10 at 28°C.
To correct the premature stop codon in the sauUSI gene of S. aureus
RN4220,thewild-typesequencefromS.aureus8325-4wasampliﬁedasa
1-kb fragment centered on the RN4220 premature stop codon and then
processed as described above.
To complement the sauUSI mutation in S. aureus NRS384 hsdRINT
sauUSIINT, the sauUSI deletion mutant was reverted to the wild type by
allelic exchange. To differentiate NRS384 hsdRINT from the NRS384 hs-
dRINT sauUSIECORV complemented strain, a new EcoRV restriction site
(http://emboss.bioinformatics.nl/cgi-bin/emboss/silent) was introduced
into the complementation construct without altering the coding se-
quence. Phenotypically, no differences were observed between NRS384
hsdRINT and NRS384 hsdRINT sauUSIECORV mutants.
To integrate pIMAY into the chromosome, a single colony from the
transformation plate was homogenized in 200 l of TSB. The suspension
was diluted 10-fold to 103, and 100 l of each dilution was spread on
BHIA plus Cm10 and incubated overnight at 37°C. For S. epidermidis,a
colonyfromthetransformationplatewasinoculatedintoBHIplusCm10
and grown overnight at 37°C, and diluted suspensions of the bacterial
growth were plated for single colonies. For both S. aureus and S. epider-
midis, large colonies were streaked on BHIA plus Cm10 and incubated
overnight at 37°C, and colony PCR analysis was performed to determine
(i) the absence of extrachromosomal plasmid DNA (with MCS oligonu-
cleotides IM151/152) (Fig. 3B) and (ii) whether plasmid integration had
occurred upstream or downstream of the gene (OUT F/D Rev oligonu-
cleotides or OUT R/A Fwd oligonucleotides,
e.g., hsdR IM5/94 or IM6/93) (Fig. 3C). Over-
night cultures of both the upstream or down-
stream crossover that were free of replicating
plasmidweregrownat28°Cwithoutchloram-
phenicol and then plated onto BHIA contain-
ing 1 g/ml anhydrotetracycline (Vetranal;
Sigma) (BHIA plus ATc). The plates were in-
cubatedat28°Cfor2days.Largecolonieswere
patched on BHIA plus ATc and BHIA plus
Cm10 and grown at 37°C overnight.
Chloramphenicol-sensitive colonies were
screenedbycolonyPCRwitholigonucleotides
to identify clones containing the desired mu-
tation (OUT F/OUT R [e.g., hsdR-IM5/6]).
Putative mutants were validated by PCR am-
pliﬁcation of genomic DNA ﬂanking the dele-
tion and DNA sequencing.
PuriﬁcationofSauUSI.TheentiresauUSI
gene was ampliﬁed from S. aureus Newman
genomic DNA with primers IM196 and
IM197, digested with NcoI and XhoI, and
cloned into the C-terminal hexahistidine tag
vector pET21d. Plasmid DNA was trans-
ferred from E. coli DH10B to BL21(DE3) for
protein expression. An overnight culture was
diluted 1:100 in fresh L broth (500 ml) and
grownat37°CtoanOD600of1.0.Thetemper-
ature of the culture was reduced to 28°C, and
expression of SauUSI was induced with 1 mM
isopropyl--d-thiogalactopyranoside (IPTG).
After 3 h, the induced cells were harvested by
centrifugation (4,000  g for 20 min at 4°C).
Thecellpelletwassuspendedin10mlofnative
E. coli lysis buffer (50 mM HEPES [pH 8],
500mMNaCl,10mMimidazole,5%glycerol,
1completeproteaseinhibitortablet[Roche]containing125UBenzonase
[Novagen] and 10 g of lysozyme). The cells were frozen at 70°C and
thenfreeze-thawed3timesbeforecentrifugation(20,000gfor30minat
4°C). The supernatant was ﬁlter sterilized (0.45-m ﬁlter) before it was
passed twice through Histrap FF column (GE Healthcare) equilibrated
with native lysis buffer at 1 ml/min. The column was then washed with
25 ml of wash buffer (native E. coli lysis buffer containing 30 mM imida-
zole). The protein was eluted from the column in ten 500-l aliquots of
native lysis buffer containing 250 mM imidazole. The SauUSI-his eluates
were visualized on a 10% SDS-polyacrylamide gel, and the protein-
containing aliquots were combined. The imidazole in the buffer was di-
luted (112,500 times) by centrifugation three times through a 50-kDa-
molecular-size-cutoffﬁlter(Millipore)withthevolumemadeupto15ml
with50mMHEPES[pH8],500mMNaCl,5mMMgCl2,and5%glycerol
(32). Aliquots were stored at 4°C.
Activity of SauUSI. pRMC2 plasmid DNA (1 g) isolated from iso-
genic E. coli strains derived from strain BW25113 containing different
methylationenzymesweremixedwithSauUSI-his(ca.425ng)inligation
buffer (50 mM Tris-Cl [pH 7.5], 10 mM MgCl2, 10 mM dithiothreitol
[DTT], 1 mM ATP [ﬁnal concentration]) and incubated at 37°C for
30 min. To separate the DNA from SauUSI, an equal volume of mem-
brane binding solution (Promega) was added, and the DNA was ethanol
precipitatedwithpelletpaint.Thesampleswerethenrunona1%agarose
gel and compared to an untreated plasmid DNA control.
Recombineering in E. coli DH10B. Strain DH10B is a high-efﬁciency
cloning strain of E. coli K-12 (Invitrogen). Even though it has the recA1
mutation, in our hands, it is still amenable to genetic manipulation by
recombineering. The plasmid pKD46 (26) was transformed into strain
DH10B using the electroporation protocol of Sheng et al. (33) and se-
FIG 7 Transformation and virulence of restriction mutants of S. aureus USA300 strain NRS384. (A)
PCR proﬁles (primers IM110/IM111) of the sauUSI region ampliﬁed from NRS384 (lanes 1), NRS384
hsdRINT sauUSIINT (lanes 2), and NRS384 hsdRINT sauUSIECORV (lanes 3) without or with EcoRV
digestion.(B)ConcentratedpRMC2DNA(5g)isolatedfromE.coliDH10B(damdcm)(lightgrey
bars) or DC10B (dam) (dark grey bars) was electroporated into the strains described above, and
transformantswereenumerated.(C)Intravenousinjectionof2106CFUinto6-to7-week-oldfemale
A/J mice. On day 7 of infection, the mice were euthanized, both kidneys were aseptically removed, and
thebacterialCFUwereenumeratedasdescribedinMaterialsandMethods.Eachsymbolrepresentsthe
value for an individual mouse, and the short black line represents the mean for the group of mice. The
broken line denotes the limit of detection at 333 CFU for the two kidneys.
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Bacterial strain, plasmid, or
oligonucleotidea Description (relevant genotype or phenotype) or sequence (5= to 3=)b
Source, reference,
or RE sitec
Escherichia coli strains
DH10B (K-12 strain) damdcm hsdRMS endA1 recA1 Invitrogen
BW25113 (K-12 strain) damdcm hsdMS hsdR514 15
IBEC55 dcm hsdMS in the BW25113 background; Dam methylation only 15
IBEC56 dam hsdMS in the BW25113 background; Dcm methylation only 15
IBEC57 dam dcm in the BW25113 background; Hsd methylation only 15
IBEC58 dam dcm hsdMS in the BW25113 background; no methylation 15
DC10B dcm in the DH10B background; Dam methylation only This study
BL21(DE3) (B strain) F– ompT hsdSB (rB
– mB
–) gal dcm (DE3); IPTG-inducible T7 RNA polymerase Novagen
Staphylococcus strains
Newman ST8; CC8 isolated in 1952 human clinical MSSA; genome sequenced 4
Newman hsdR Newman with a deletion of Sae0139 This study
Newman sauUSI Newman with a deletion of Sae2386 This study
Newman hsdR sauUSI Newman with a deletion of both Sae0139 and Sae2386 This study
Newman hsdR sauUSIECORV Restoration of Sae2386 in the hsdR sauUSI background This study
Newman nudix Newman with a deletion of Sae2385 This study
NRS384 USA300-14 clone obtained from NARSA NARSA collection
NRS384 hsdRINT Targetron insertion at nucleotide 735 of hsdR This study
NRS384 sauUSIINT Targetron insertion at nucleotide 739 of sauUSI This study
NRS384 sauUSIINT hsdRINT Targetron insertion in hsdR made in the NRS384sauUSIINT background This study
NRS384 sauUSIECORV hsdRINT Restoration of the sauUSI mutation with a silent EcoRV site in the double insertion mutant
background
This study
RN4220 ST8; CC8; chemically mutagenized derivative of 8325-4, transformable with E. coli DNA;
premature stop codon in both hsdR and sauUSI
11
RN4220 sauUSI Nonsense mutation in sauUSI corrected to wild type with 8325-4 sequence This study
Cowan ST30; CC30 MSSA;high-level protein A producer; ATCC 12598 25
Cowan sauUSI Deletion of sauUSI This study
N315 ST5 CC5 MSSA; genome sequenced 29
LAC ST8 CC8 CA-MRSA; USA300 6
MRSA252 ST36 CC30 MRSA; genome sequenced 36
Oxford 13 ST22 CC22 37
Oxford 19 ST10 CC16 37
Oxford 71 ST1 CC1 37
Oxford 159 ST25 CC25 37
Oxford 207 ST15 CC15 37
Oxford 233 ST45 CC45 37
Oxford 560 ST121 CC51 37
Oxford 3177 ST97 CC16 37
RP62a Methicillin-resistant, bioﬁlm-forming Staphylococcus epidermidis isolate; genome sequenced 24
RP62a mcrR Deletion of Serp2052; able to accept DNA at a low frequency from wild-type E. coli This study
Enterococcus faecalis strains
OG1RF Rifampin- and fusic acid-resistant E. faecalis clone derived for OG1 38
JH2-2 Rifampin- and fusic acid-resistant E. faecalis clone derived for JH2 39
V583 Vancomycin-resistant clinical isolate of E. faecalis 40
Plasmids
pNL9164 Temperature-sensitive targetron plasmid for S. aureus pT181 replicon; Ampr Eryr Sigma
pNL9164(hsdR) pNL9164 retargeted for hsdR of NRS384 This study
pNL9164(sauUSI) pNL9164 retargeted for sauUSI of NRS384 This study
pKD4 Plasmid for ampliﬁcation of frt-kan-frt for E. coli gene deletion; Ampr Kanr 26
pKD46 E. coli temperature-sensitive plasmid containing  red recombinase genes under the control
of an arabinose-inducible promoter; Ampr
26
pCP20 E. coli temperature-sensitive plasmid containing ﬂp required for antibiotic marker excision;
Ampr Cmr
10
pIMC Site-speciﬁc integrating vector; p15A low-copy-number origin of replication; RP4
conjugative origin of transfer and Phelp-driven chloramphenicol resistance marker;
pBluescript MCS; Cmr
34
pKOR1 Temperature-sensitive shuttle vector for allelic exchange in S. aureus; Ampr Cmr 19
pVE6007 pWV01ts-derived plasmid that cannot replicate in E. coli;C m r 21
pIMC5 Temperature-sensitive Gram-positive replicon from pVE6007 with an E. coli replicon; MCS
and antibiotic resistance from pIMC; Cmr (IM46/IM47/IM48/IM49)
This study
pIMAY pIMC5 with tetracycline; inducible secY antisense from pKOR1; Cmr (IM72/IM73) This study
pIMAYhsdR A deletion encompassing the entire hsdR gene (between the ATG and TAA codons);
ampliﬁed from Newman (IM93/IM3/IM4/IM94)
This study
(Continued on following page)
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Bacterial strain, plasmid, or
oligonucleotidea Description (relevant genotype or phenotype) or sequence (5= to 3=)b
Source, reference,
or RE sitec
pIMAYsauUSI(CC8) A deletion encompassing the entire sauUSI gene (between the ATG and TAA codons);
ampliﬁed from Newman (IM89/IM90/IM91/IM92)
This study
pIMAYsauUSI(CC30) A deletion encompassing the entire sauUSI gene (between the ATG and TAA codons);
ampliﬁed from Cowan (IM89/IM90/IM91/IM150)
This study
pIMAYmcrR(S.epi) A deletion encompassing the entire mcrR gene (between the ATG and TAA codons);
ampliﬁed from RP62a (IM216/IM217/IM218/IM219)
This study
pIMAY sauUSIEcoRV A silent EcoRV site was introduced into the middle of the sauUSI gene (with DNA ﬂanking
for gene restoration in the sauUSI mutant) (IM89/IM350/IM351/IM92)
This study
pIMAY(RN4220sauUSI) A 1-kb fragment ampliﬁed from Newman surrounding the premature stop codon in RN4220
sauUSI (IM108/IM109)
This study
pIMAYnudix A deletion encompassing the entire putative nudix gene (between the ATG and TAA
codons); ampliﬁed from Newman (IM222/IM223/IM224/IM225)
This study
pET21d C-terminal hexahistadine tagging vector; Ampr Novagen
pET21dsauUSI The entire sauUSI gene ampliﬁed from Newman and fused to a C-terminal His tag
(IM196/IM197)
This study
Oligonucleotides
IM46 (pVE6007 F) ATATGCATGCGTTTTAGCGTTTATTTCGTTTAGTTATCGG SphI
IM47 (pVE6007 R) GTATTGCTATTAATCGCAACATCAAACC
IM48 (pIMC F) GATGTTGCGATTAATAGCAATACATTCTATAATAGAAGGTATGGAGGATG
IM49 (pIMC R) AGATCTCCTCTCGCCTGTCCCCTCAGTTCAGTAATTTCC BglII
IM72 (anti secY F) ATATAGATCTTGATCTAATGATTCAAACCCTTGTG BglII
IM73 (anti secY R) ATATGCATGCTGAAGTTACCATCACGGAAAAAGG SphI
IM93 (hsdR-AFwd) ATATGGTACCGTGGCCACACATTACAGTATTCCC KpnI
IM2 (hsdR-B) CATTCATATCCCCTTCCATACACTTTCTATTGC
IM3 (hsdR-C) TATGGAAGGGGATATGAATGTAATGATTCAGCCCCCTCGCTAGATTAGTG
IM94 (hsdR-DRev) ATATGAGCTCATTCATCTTTGTATTCTTTCATGTTTCC SacI
IM5 (hsdR-outF) AGTCATAGTGAATTGCAGTCAATTGC
IM6 (hsdR-outR) ATATAACAAGAACTTAATTTCAGCCG
IM89 (sauUSI-AFwd) ATATGGTACCGTGTATGAAAATGCATGGAGTAGAGC KpnI
IM90 (sauUSI-B) CATATTATCCCTCAGTCATAATTTTATTAACG
IM91 (sauUSI-C) CGTTAATAAAATTATGACTGAGGGATAATATGTAATGTAAACCGAAAAATG
AATGTTAGTAAAG
IM92 (sauUSI-DRev) ATATGAGCTCCCAATCCTCTGGATTCCATATTCTTTCC SacI
IM150 (CC30 sauUSI-DRev) ATATGAGCTCAAACTCTTCGTCACGAAATCCTTCC SacI
IM110 (sauUSI-OUT F) ACAGCCCCAAGACAATACTTTTCAC
IM111 (sauUSI-OUTR) ATACAGGACCAATCCTCTGGATTCC
IM108 (RNsauUSIcomp)F ATATGGTACCGTGCATTAGATGTTAGAGAAGTAAACC KpnI
IM109 (RNsauUSIcomp)R ATATGAGCTCATTTAATGATACTGCATCCAATGAATTG SacI
IM350 (384sauUSIcomp)B GATATCACTTTCTAATGCTGCTTGTAACC EcoRV
IM351 (384sauUSIcomp)C ACAAGCAGCATTAGAAAGTGATATCTTATGTCCATTTCATTATTTTGGTGTG EcoRV
IM196 (His-SauUSI F) ATATCCATGGGTAGATTACTAAATGATTTCAATC NcoI
IM197 (His-SauUSI R) ATATCTCGAGATTTGTTAGATAACGATATATATCATCTC XhoI
IM216 (Se mcrR-AFwd) ATATGTCGACTCTAATATATTAAGTATGTAAACCACG SalI
IM217 (Se mcrR-B) CAATCTAATTCTCCTCTATTATACG
IM218 (Se mcrR-C) GTATAATAGAGGAGAATTAGATTGTAATTACTTATACTAAATTATTATTTATTG
IM219 (Se mcrR-DRev) ATATGAATTCTGAATCACAGATCAAAAATGAAGACC EcoRI
IM220 (Se mcrR-OUTF) GAATTGAAAATTTTAGGTATTCAGATGG
IM221 (Se mcrR-OUTR) AAACCTTTAATAATTATCAAGACAGC
IM222 (nudix-AFwd) ATATGGTACCACCTTCACCAAGACCGAATTTTCC KpnI
IM223 (nudix-B) CATAAGACTCACCCTTCAATTTAAAATC
IM224 (nudix-C) TTAAATTGAAGGGTGAGTCTTATGTAATATGAGTAGATTACTAAATGATTTC
IM225 (nudix-DRev) ATATGAGCTCATAGTAGACAGTAAAACATTATGC SacI
IM226 (nudix OUT F) TTTAAATAACGCGCTAAACCTAATGC
IM227 (nudix OUT R) CACTATCAACTAAATCGCCATTTTTC
IM261 (Ec dcm F) TGTAATTATGTTAACCTGTCGGCCATCTCAGATGGCCGGTGAAATCTATGGTG
TAGGCTGGAGCTGCTTC
IM262 (Ec dcm R) TTGTGCCTCTTGCTGACGCAACGCCACCGCCTGTTTGATTTTTGGCTCAAGGTCCAT
ATGAATATCCTCCTTAG
IM251 (Ec dcm OUTF) AGAAGAGACGCGTCGCCTGCTCC
IM252 (Ec dcm OUTR) TACTGGTCACGTTGGGAAAATATCTC
IMS80 (hsdR IBS) AAAAAAGCTTATAATTATCCTTACTTCTCCCGCATGTGCGCCCAGATAGGGTG HindIII
IMS81 (hsdR EBS1d) CAGATTGTACAAATGTGGTGATAACAGATAAGTCCCGCAT
ACTAACTTACCTTTCTTTGT
BsrGI
(Continued on following page)
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was made electrocompetent as described above, except that the cells were
grownat30°C(insteadof37°C),andoncetheculturereachedanOD600of
0.4, ﬁlter-sterilized arabinose (Sigma) was added to a ﬁnal concentration
of 0.2%. The culture was incubated for1ht oinduce exo, beta, and gam
expression, and the cells were washed and stored at 70°C. The plasmid
pKD4 (26) was used as a template to PCR amplify the kanamycin resis-
tance marker ﬂanked by two ﬂippase recognition target (FRT) sites. The
forward and reverse primers (IM261/IM262) were tailed with 50 nucleo-
tidescomplementaryuptothedcmgenestartcodonand23codonsdown
fromthestopcodontogenerateanin-framedeletionwithinthedcmgene.
The linear amplimer was electroporated into the electrocompetent E. coli
DH10B(pKD46), and transformants were selected on LBA containing
50 g/ml of kanamycin at 37°C. One kanamycin-resistant clone was se-
lected and plated on LBA at 43°C to eliminate pKD46. An ampicillin-
sensitive derivative was made competent and transformed at 30°C with
pCP20(26)(selectedonLBAwith10g/mlCm)toexcisethekanamycin
resistance marker. Finally, pCP20 was eliminated by plating at 43°C to
yield E. coli DH10Bdcm (called DC10B). The loss of cytosine methyl-
ation was conﬁrmed phenotypically through the inability of SauUSI to
digest DC10B plasmid or genomic DNA and transformation of wild-type
S. aureus and S. epidermidis strains with a shuttle plasmid isolated from
DC10B.
Creation of targetron insertion mutants in S. aureus NRS384. Tar-
getron insertion mutants were created in S. aureus NRS384 following the
protocol of the manufacturer (Sigma) (17). Primers were designed to
retarget the intron for hsdR (IMS80/IMS81/IMS82) or sauUSI (IMS85/
IMS86/IMS87). To amplify the 350-bp retargeted amplicon for hsdR or
sauUSI, the above primers were combined with IMSuni. The amplicon
was digested with HindIII/BrsGI and cloned into similarly cut pNL9164.
pNL9164hsdR or pNL9164sauUSI was then passaged through S. aureus
RN4220 at 30°C before being electroporated into NRS384 at 30°C. A sin-
glecolonywasstreakedonTrypticasesoyagar(TSA)plus25gofEmper
ml (Em25) containing 10 M CdCl2 and incubated overnight to induce
intron mobilization. Single colonies were screened for insertion of the
intron into hsdR (IMS83/IMS84) or sauUSI (IMS90/IMS91) by colony
PCR. The plasmid was cured by overnight growth in broth at 43°C fol-
lowed by plating onto TSA at 30°C. Colonies were patched onto TSA and
TSA plus Em to identify plasmid-free isolates. The double mutant was
created in the sauUSIINT background.
Intravenous infection of A/J mice. Overnight cultures of S. aureus
NRS384, hsdRINT, sauUSIINT, hsdRINT sauUSIINT, and hsdRINT sau-
USIECORVstrainswerediluted1:100inTSBandgrowntoanOD600of0.5
to 0.6. The cells were harvested by centrifugation and washed twice with
phosphate-buffered saline (PBS) and resuspended to an OD600 o f1( 5
108 CFU/ml). The inoculum was diluted to 2  107 CFU/ml, and 100 l
was injected into the tail vein of a 6- to 7-week-old female A/J mouse.
Eightmicewereusedforeachstrain.Atday7postinfection,themicewere
euthanized,andthetotalbacterialloadsinbothkidneysweredetermined
by serial dilution and plating.
Nucleotide sequence accession number. The nucleotide sequence of
pIMAY was deposited in GenBank under accession number JQ621981.
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IMS82 (hsdR EBS2) TGAACGCAAGTTTCTAATTTCGGTTAGAAGTCGATAGAGGAAAGTGTCT
IMS83 (hsdR OUT F) AGTATACGACTTACCTCAA
IMS84 (hsdR OUT R) TCAGTTGTTTCTGCCACG
IMS85 (sauUSI IBS) AAAAAAGCTTATAATTATCCTTAAAAGACAAGGCGGTGCGCCCAGATAGGGTG HindIII
IMS86 (sauUSI EBS1d) CAGATTGTACAAATGTGGTGATAACAGATAAGTCAAGGCG
TTTAACTTACCTTTCTTTGT
BsrGI
IMS87 (sauUSI EBS2) TGAACGCAAGTTTCTAATTTCGGGTTTCTTTCCGATAGAGGAAAGTGTCT
IMS90 (sauUSI OUT F) ATGAGTAGATTACTAAATG
IMS91 (sauUSI OUT R) CGTTACTACGTTTGAACC
IMSuni CGAAATTAGAAACTTGCGTTCAGTAAAC
IM151 (pIMAY MCS F) TACATGTCAAGAATAAACTGCCAAAGC
IM152 (pIMAY MCS R) AATACCTGTGACGGAAGATCACTTCG
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